enzyme inhibitors

Preferred Label : enzyme inhibitors;

MeSH definition : Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction.;

MeSH synonym : inhibitors, enzyme; Enzyme Inhibitor; Inhibitor, Enzyme;

MeSH annotation : GEN only; prefer specifics; general or unspecified; prefer specifics;

Wikipedia link : https://en.wikipedia.org/wiki/Enzyme inhibitors;

Is substance : O;

action pharmacologique : O;

Details

Origin ID

D004791;

UMLS CUI

C0014432;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Enzyme inhibitor (disposition) [SNOMED CT concept]
- Expected Adverse Event [NCIt concept]
- Experimental Allergic Encephalomyelitis [NCIt concept]
- Substance with enzyme mechanism of action (substance) [SNOMED CT concept]
Currated CISMeF NLP mapping
- Enzyme Inhibitor [NCIt concept]
- Product containing enzyme inhibitor (product) [SNOMED CT concept]
- Substance with enzyme inhibitor mechanism of action (substance) [SNOMED CT concept]
- enzyme inhibitor [IUPAC Term]
Indexing information
- 1-(3-cyano-4-(1H-pyrazol-4-yl)phenyl)-3-(5-(pyridin-4-yl)-1,3,4-thiadiazol-2-yl)urea [MeSH Supplementary Concept]
- 1-valyl-4-phenylpiperazine [MeSH Supplementary Concept]
- 2,4-dichloro-N-(3-fluorophenyl)-5-(4-morpholinylsulfonyl)benzamide [MeSH Supplementary Concept]
- 2-((3,5-difluoro-3'-methoxy-1,1'-biphenyl-4-yl)amino)nicotinic acid [MeSH Supplementary Concept]
- 2-(1-benzylindol-3-ylmethylene)-1-azabicyclo(2.2.2)octan-3-ol [MeSH Supplementary Concept]
- 2-(2-methylfuran-3-carboxamido)-3-phenylpropanoic acid [MeSH Supplementary Concept]
- 2-(4-fluoro-3-(trifluoromethyl)phenoxy)-N-(phenylmethyl)butanamide [MeSH Supplementary Concept]
- 2-amino-1,3',3'-trimethyl-7'-(pyrimidin-5-yl)-3',4'-dihydro-2'H-spiro(imidazole-4,1'-naphthalen)-5(1H)-one [MeSH Supplementary Concept]
- 4-(2-hydroxy-4-methoxyphenyl)-4-oxobutanoic acid [MeSH Supplementary Concept]
- 4-(3-chloro-5-(trifluoromethyl)pyridin-2-yl)-N-(4-methoxypyridin-2-yl)piperazine-1-carbothioamide [MeSH Supplementary Concept]
- 4-(phenylamino)-7H-pyrrolo(2,3-d)pyrimidine [MeSH Supplementary Concept]
- 4-amino-1-octylquinaldinium [MeSH Supplementary Concept]
- 4-benzoyl-2-nitrophenyl thiocyanate [MeSH Supplementary Concept]
- 4-oxo-4-(2-((5-phenoxy-1H-indol-2-yl)carbonyl)hydrazino)-N-(4-phenylbutan-2-yl)butanamide [MeSH Supplementary Concept]
- 6H-6-imino-(2,3,4,5-tetrahydropyrimido)(1,2-c)-(1,3)benzothiazine [MeSH Supplementary Concept]
- ATPase inhibitory protein, aprotinin [MeSH Supplementary Concept]
- AZIN1 protein, human [MeSH Supplementary Concept]
- AZIN2 protein, human [MeSH Supplementary Concept]
- DIT33 protein, dirofilaria immitis [MeSH Supplementary Concept]
- GCKR protein, human [MeSH Supplementary Concept]
- GNE-629 [MeSH Supplementary Concept]
- GSK1322322 [MeSH Supplementary Concept]
- GSK343 [MeSH Supplementary Concept]
- I-T protein, Drosophila [MeSH Supplementary Concept]
- ITF1671 protein, synthetic [MeSH Supplementary Concept]
- J 104871 [MeSH Supplementary Concept]
- MBIP protein, human [MeSH Supplementary Concept]
- ME1071 [MeSH Supplementary Concept]
- N-(2,6-dimethylphenyl)-2-(N-(2-furylmethyl)(4-(1,2,3,4-tetraazolyl)phenyl)carbonylamino)-2-(4-hydroxy-3-methoxyphenyl)acetamide [MeSH Supplementary Concept]
- N-(3-(2-amino-6-methylpyrimidin-4-ylamino)phenyl)-4-(quinolin-4-ylamino)benzamide [MeSH Supplementary Concept]
- N-3-methoxybenzyllinoleamide [MeSH Supplementary Concept]
- N-methyl-N-((3-(4-pyridinyl)phenyl)methyl)-4'-(aminocarbonyl)(1,1'-biphenyl)-4-yl ester, carbamic acid [MeSH Supplementary Concept]
- NLRP4 protein, human [MeSH Supplementary Concept]
- Oaz3 protein, mouse [MeSH Supplementary Concept]
- PAK1IP1 protein, human [MeSH Supplementary Concept]
- PCSK1N protein, human [MeSH Supplementary Concept]
- PF-458 [MeSH Supplementary Concept]
- PPP1R14D protein, human [MeSH Supplementary Concept]
- PPP1R2C protein, human [MeSH Supplementary Concept]
- PR-01 steroid [MeSH Supplementary Concept]
- PR-07 steroid [MeSH Supplementary Concept]
- RHI001 [MeSH Supplementary Concept]
- RHI002 [MeSH Supplementary Concept]
- RNH1 protein, human [MeSH Supplementary Concept]
- Rnh1 protein, rat [MeSH Supplementary Concept]
- SK&F 104976 [MeSH Supplementary Concept]
- SN 34037 [MeSH Supplementary Concept]
- SaI14 protein, streptomyces aureofaciens [MeSH Supplementary Concept]
- artoxanthochromane [MeSH Supplementary Concept]
- barstar protein, bacillus amyloliquefaciens [MeSH Supplementary Concept]
- butylacetylphosphonate [MeSH Supplementary Concept]
- chandrananimycin A [MeSH Supplementary Concept]
- dihydronovobiocin [MeSH Supplementary Concept]
- endonuclease G inhibitor, drosophila [MeSH Supplementary Concept]
- epostatin [MeSH Supplementary Concept]
- ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate [MeSH Supplementary Concept]
- fludarabine [MeSH Supplementary Concept]
- lodamin [MeSH Supplementary Concept]
- methyl 6-S-(galactofuranosyl)-6-thiogalactofuranoside [MeSH Supplementary Concept]
- ornithine decarboxylase antizyme [MeSH Supplementary Concept]
- ornithine decarboxylase antizyme inhibitor [MeSH Supplementary Concept]
- piperazine-1-carboxamidine [MeSH Supplementary Concept]
- thrombostasin protein, haematobia irritans [MeSH Supplementary Concept]
- valine-pyrrolidide [MeSH Supplementary Concept]
Manual BTNT mappings - CISMeF
- succinate dehydrogenase inhibitors [SYNODOS term]
MeSH Descriptor(s) used for indexing
- enzymes [MeSH Descriptor]
Record concept(s)
- enzyme inhibitors [MeSH concept]
See also
- sulfhydryl reagents [MeSH Descriptor]
See also (suggested by CISMeF)
- enzymes [MeSH Descriptor]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- (2-(4-(2-benzimidazol-2ylthio)ethyl)piperazin-1yl)-N-(2,4-bis(methylthio)-6-methyl-3-pyridyl)acetamide [MeSH Supplementary Concept]
- (2-boronoethyl)-cysteine [MeSH Supplementary Concept]
- (R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide [MeSH Supplementary Concept]
- 1,2,3-O-acetyl-1,2,3-demethyl-N-(4'-nitrobenzoyl)deacetylthiocolchicine [MeSH Supplementary Concept]
- 1,3,4,5,6,7,8,10-octahydro-14-hydroxy-12-methoxy-11-methyl-4-(3-methyl-1,2,4-oxadiazol-5-yl)-6-thioxo-9,2,5-benzoxanthiaazacyclododecine-10-one [MeSH Supplementary Concept]
- 1,3,4,5,6,7,8,9,10,12-decahydro-16-hydroxy-14-methoxy-13-methyl-4-(3-methyl-1,2,4-oxadiazol-5-yl)-6-thioxo-11,2,5-benzoxathiaazacyclotetradecine-12-one [MeSH Supplementary Concept]
- 1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea [MeSH Supplementary Concept]
- 1-(3'-hydroxypropyl)-4,6,8-trimethylfuro(2,3-h)quinolin-2(1H)-one [MeSH Supplementary Concept]
- 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine [MeSH Descriptor]
- 1-2-isopropoxy-2-oxidodihydro-4H,6H-spiro(furo(3,2-d)(1,3,2)dioxaphosphinine-7,2'-oxetan)-6-yl)pyrimidine-2,4(1H,3H)-dione [MeSH Supplementary Concept]
- 1-Deoxynojirimycin [MeSH Descriptor]
- 1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-(2,6-dimethyl-4-pyridinyl)-4-oxo-3-quinolinecarboxyic acid [MeSH Supplementary Concept]
- 1-cyclopropyl-6-hydroxy-8-methyl-4-oxo-7-(1,2,3,4-tetrahydro-2-isoquinolyl)-1,4-dihydroquinoline-3-carboxylic acid [MeSH Supplementary Concept]
- 10,11-methylenedioxy-20-camptothecin [MeSH Supplementary Concept]
- 13-hydroperoxylinoleic acid [MeSH Supplementary Concept]
- 1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one [MeSH Supplementary Concept]
- 2',3'-dideoxyguanosine 5'-diphosphate [MeSH Supplementary Concept]
- 2',5-difluoro-2'-deoxy-1-arabinosyluracil [MeSH Supplementary Concept]
- 2'-deoxy-2'-methylenecytidine [MeSH Supplementary Concept]
- 2,2'-thiodiethanol [MeSH Supplementary Concept]
- 2,3-dihydro-9-ethyl-5-fluoro-9-hydroxy-4-methyl-1H,12H-benzo(de)pyrano(3',4'-6,7)indolizino(1,2-b)quinoline-10,13(9H,15H)-dione [MeSH Supplementary Concept]
- 2,3-dihydroindolizino(7,6,5-kl)acridinium chloride [MeSH Supplementary Concept]
- 2,3-dimethoxy-8,9-methylenedioxy-11H-indeno(1,2-c)isoquinoline [MeSH Supplementary Concept]
- 2,4-diaminohypoxanthine [MeSH Supplementary Concept]
- 2,4-dioxo-N-(4-(4-pyridyl)phenyl)-1H-quinazoline-6-sulfonamide [MeSH Supplementary Concept]
- 2,5-bis(4-hydroxy-3-methoxybenzylidene)cyclopentanone [MeSH Supplementary Concept]
- 2,5-di-tert-butylhydroquinone [MeSH Supplementary Concept]
- 2,5-dideoxy-2,5-imino-altritol 1,6- bisphosphate [MeSH Supplementary Concept]
- 2-((1S)-1-((6-amino-5-cyano-4-pyrimidinyl)amino)ethyl)-6-fluoro-N-methyl-3-(2-pyridinyl)-4-quinolinecarboxamide [MeSH Supplementary Concept]
- 2-(2'-(dimethylamino)ethyl)-1,2-dihydro-7-ethoxydibenz(de,h)isoquinoline-1,3-dione [MeSH Supplementary Concept]
- 2-(2-dimethylamino)-6-thia-2-azabenzo(def)chrysene-1,3-dione [MeSH Supplementary Concept]
- 2-(3',4'-dihydroxyphenyl)-5,7-dihydroxy-3-(2'',6''-di-O-(3'''-(4-fluorophenylpropanoyl)))galactosyl-4H-chromen-4-one [MeSH Supplementary Concept]
- 2-(4-methoxyphenyl)-5-((4-methylpiperazin-1-yl)-3H-imidazo(4,5-b)pyridin-2-yl)-3H-imidazo(4,5-b)pyridine [MeSH Supplementary Concept]
- 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one [MeSH Supplementary Concept]
- 2-(4-nitrophenyl)-4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazole [MeSH Supplementary Concept]
- 2-(phenyl)amino-aceto-hydrazide [MeSH Supplementary Concept]
- 2-(phenylamino)aceto-hydrazide [MeSH Supplementary Concept]
- 2-acyl-5,8-dimethoxy-1,4-naphthoquinone [MeSH Supplementary Concept]
- 2-deoxy-2,3-dehydro-N-acetylneuraminic acid [MeSH Supplementary Concept]
- 2-iodosobenzoic acid [MeSH Supplementary Concept]
- 2-mercaptoethylguanidine [MeSH Supplementary Concept]
- 2-methyl-3-(4-(3-pyridinylmethyl)phenyl)-2-propenoic acid [MeSH Supplementary Concept]
- 2-nitro-5-thiocyanobenzoic acid [MeSH Supplementary Concept]
- 2-tert-butylhydroquinone [MeSH Supplementary Concept]
- 3'-deamino-3'-hydroxydoxorubicin [MeSH Supplementary Concept]
- 3(S)-thiomethyl pyrrolidine [MeSH Supplementary Concept]
- 3,3',4',5-tetrachlorosalicylanilide [MeSH Supplementary Concept]
- 3,4,5-trihydroxybenzamidoxime [MeSH Supplementary Concept]
- 3,4-dihydroxybenzohydroxamic acid [MeSH Supplementary Concept]
- 3,5-diethoxy-4-aminomethylpyridine [MeSH Supplementary Concept]
- 3,9-dibromo-12-(4-O-methylglucopyranosyl)-6,7.12,13-tetrahydroindolo(2,3-a)pyrrolo(3,4-c)carbazole-5,7-dione [MeSH Supplementary Concept]
- 3-(((16beta,17beta)-3-(2-bromoethyl)-17-hydroxyestra-1,3,5(10)-trien-16-yl)methyl)benzamide [MeSH Supplementary Concept]
- 3-(1H-indol-3-yl)-2,3-dihydro-4H-furo(3,2-c)chromen-4-one [MeSH Supplementary Concept]
- 3-(7-azaindolyl)-4-indolylmaleimides [MeSH Supplementary Concept]
- 3-Iodobenzylguanidine [MeSH Descriptor]
- 3-O-(N-(phenylsulfonyl)carbamoyl-17beta-N-(phenylsulfonyl)amide)betulinic acid [MeSH Supplementary Concept]
- 3-O-(glucopyranosyl-1-4-arabinopyranosyl)hederagenin [MeSH Supplementary Concept]
- 3-O-alpha-L-arabinopyranosyl-oleanolic acid [MeSH Supplementary Concept]
- 3-O-coumaroylbetulinic acid [MeSH Supplementary Concept]
- 3-acetylpyridine [MeSH Supplementary Concept]
- 3-amino-2,3-dihydropyrid-4-one [MeSH Supplementary Concept]
- 3-amino-7-(3-(1-aminoethyl)pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-8-methyl-1H-quinazoline-2,4-dione [MeSH Supplementary Concept]
- 3-beta-(2-(diethylamino)ethoxy)androst-5-en-17-one [MeSH Supplementary Concept]
- 3-bis((2,5-dioxo-1-(4-((E)-2-phenyldiazen-1-yl)phenyl)pyrrolidin-3-yl)sulfanyl) butanedioic acid [MeSH Supplementary Concept]
- 3-chlorocatechol [MeSH Supplementary Concept]
- 3-chlorotyrosine [MeSH Supplementary Concept]
- 3-deazaaristeromycin [MeSH Supplementary Concept]
- 3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene [MeSH Supplementary Concept]
- 3-mercaptopicolinic acid [MeSH Supplementary Concept]
- 3-mercaptopropionic acid [MeSH Descriptor]
- 3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid [MeSH Supplementary Concept]
- 4'-O-demethyl-4-(4''-(benzimidazol-2''-yl)anilino)-4-desoxypodophyllotoxin [MeSH Supplementary Concept]
- 4,11-dimethoxynaphtho(2,3-f)indole-5,10-dione [MeSH Supplementary Concept]
- 4,4'-(1,2-dimethyl-1,2-ethanediyl)bis-2,6-piperazinedione [MeSH Supplementary Concept]
- 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline [MeSH Supplementary Concept]
- 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole [MeSH Supplementary Concept]
- 4-(5-(piperidin-4-ylmethoxy)-2-(p-tolyl)pyridin-3-yl)benzonitrile [MeSH Supplementary Concept]
- 4-Chloro-7-nitrobenzofurazan [MeSH Descriptor]
- 4-amidinoindan-1-one 2'-amidinohydrazone [MeSH Supplementary Concept]
- 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine [MeSH Supplementary Concept]
- 4-amino-5-hexynoic acid [MeSH Supplementary Concept]
- 4-benzoyl-1-(4-methyl-imidazol-5-yl)carbonylthiosemicarbazide [MeSH Supplementary Concept]
- 4-bromophenacyl bromide [MeSH Supplementary Concept]
- 4-chloromercuribenzenesulfonate [MeSH Descriptor]
- 4-demethoxy-3'-deamino-3'-hydroxydoxorubicin [MeSH Supplementary Concept]
- 4-demethoxy-3'-deamino-4'-deoxy-4'-aminodaunorubicin [MeSH Supplementary Concept]
- 4-hydroxycoumarins [MeSH Descriptor]
- 4-hydroxyphenylglycine [MeSH Supplementary Concept]
- 4-methoxybenzo(a)phenazine-11-carboxylic acid (2-(dimethylamino)-1-methylethyl)amide [MeSH Supplementary Concept]
- 4-methyl-2-((2-methylbenzyl) amino)-1,3-thiazole-5-carboxylic acid [MeSH Supplementary Concept]
- 4-methyl-7-(tetradecanoyl)-2H-1-benzopyran-2-one [MeSH Supplementary Concept]
- 5',8'-dihydroxy-5,8-dimethoxy-6,6'-dimethyl-7,3'-binaphthyl-1,4,1',4'-tetraone [MeSH Supplementary Concept]
- 5',8'-dihydroxy-6,6'-dimethyl-7,3'-binaphthyl-1,4,1',4'-tetraone [MeSH Supplementary Concept]
- 5'-methylthioadenosine [MeSH Supplementary Concept]
- 5'-thioadenosine [MeSH Supplementary Concept]
- 5,11-dimethyl-5H-indolo(2,3-b)quinoline [MeSH Supplementary Concept]
- 5,8-bis(2-aminoethylamino)-1-azaanthracene-9,10-dione [MeSH Supplementary Concept]
- 5-((methylthio)methyl)-2'-deoxyuridine [MeSH Supplementary Concept]
- 5-(2-(5-chloroindol-3-yl)vinyl)pyrazole [MeSH Supplementary Concept]
- 5-benzylacyclouridine [MeSH Supplementary Concept]
- 5-ethyl-9,10-difluoro-1,4,5,13-tetrahydro-5-hydroxy-3H,15H-oxepino(3',4'-6,7)indolizino(1,2-b)quinoline-3,15-dione [MeSH Supplementary Concept]
- 5-fluoro-2'-deoxycytidine 5'-monophosphate [MeSH Supplementary Concept]
- 5-iodotubercidin [MeSH Supplementary Concept]
- 5-phenyl-2-(2'-(benzimidazol-5''-yl)benzimidazol-5'-yl)benzimidazole [MeSH Supplementary Concept]
- 5-propenyl-dUTP [MeSH Supplementary Concept]
- 5-vinyl-1-arabinofuranosyluracil [MeSH Supplementary Concept]
- 6-((2-(dimethylamino)ethyl)amino)-3-hydroxy-7H-indeno(2,1-c)quinolin-7-one [MeSH Supplementary Concept]
- 6-((4-chlorophenyl)methyl)-4-hydroxy-2,3-dihydropyridazin-3-one [MeSH Supplementary Concept]
- 6-(3-(2-hydroxyethyl)amino-1-propyl)-5,6-dihydro-2,3-dimethoxy-8,9-methylenedioxy-5,11-dioxo-11H-indeno(1,2-)isoquinoline [MeSH Supplementary Concept]
- 6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid [MeSH Supplementary Concept]
- 6-(4-fluorophenyl)-2,3-dihydro-5-(4-pyridinyl)imidazo(2,1-b)thiazole [MeSH Supplementary Concept]
- 6-acyl-5,8-dimethoxy-1,4-naphthoquinone [MeSH Supplementary Concept]
- 6-anilino-5,8-quinolinedione [MeSH Supplementary Concept]
- 6-methoxy-2-naphthylacetic acid [MeSH Supplementary Concept]
- 7-(3-(1-aminoethyl)pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-8-methyl-1H-quinazoline-2,4-dione [MeSH Supplementary Concept]
- 7-(4-(4-tert-butylbenzyloxy)-1H-indazol-3-ylmethylsulfanyl)-4-methylcoumarin [MeSH Supplementary Concept]
- 7-ketocholesterol [MeSH Supplementary Concept]
- 7-nitroindazole [MeSH Supplementary Concept]
- 7-tert-butyldimethylsilyl-10-hydroxyhomocamptothecin [MeSH Supplementary Concept]
- 8-((4-chlorophenyl)thio)cyclic-3',5'-AMP [MeSH Supplementary Concept]
- 8-(4-chlorophenylthio)guanosine 3',5'-cyclic monophosphorothioate [MeSH Supplementary Concept]
- 8-amino-2'-nordeoxyguanosine [MeSH Supplementary Concept]
- 8-aminoguanosine [MeSH Supplementary Concept]
- 8-azabatracylin [MeSH Supplementary Concept]
- 8-desaminobatracylin [MeSH Supplementary Concept]
- 8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid [MeSH Supplementary Concept]
- 8-methoxy-2'-deoxyguanosine [MeSH Supplementary Concept]
- 9'-fluoro-10'-(4-methyl-1-piperazinyl)-7'-oxospiro(cyclopropane-1,3'(2'H)-(7H)pyrido(1,2,3-de)(1,4)benzoxazine)-6'-carboxylic acid [MeSH Supplementary Concept]
- 9-(2-hydroxy-3-nonyl)adenine [MeSH Supplementary Concept]
- 9-bromophenazine-4-carboxamide [MeSH Supplementary Concept]
- A 62176 [MeSH Supplementary Concept]
- A 85226 [MeSH Supplementary Concept]
- ABT 702 [MeSH Supplementary Concept]
- ACH 702 [MeSH Supplementary Concept]
- ACTH (4-7), Pro-Gly-Pro- [MeSH Supplementary Concept]
- AG 127 [MeSH Supplementary Concept]
- ASP8477 [MeSH Supplementary Concept]
- BE 10988 [MeSH Supplementary Concept]
- BE 13793C [MeSH Supplementary Concept]
- BE 22179 [MeSH Supplementary Concept]
- BGP 15 [MeSH Supplementary Concept]
- BJ-1301 [MeSH Supplementary Concept]
- BJJF078 [MeSH Supplementary Concept]
- BM 15766 [MeSH Supplementary Concept]
- BM 2419-1 [MeSH Supplementary Concept]
- BM 2419-2 [MeSH Supplementary Concept]
- BMH-21 [MeSH Supplementary Concept]
- BOF 4272 [MeSH Supplementary Concept]
- CB-1158 [MeSH Supplementary Concept]
- CJ 12371 [MeSH Supplementary Concept]
- CJ 12372 [MeSH Supplementary Concept]
- CJ 12373 [MeSH Supplementary Concept]
- CM544 [MeSH Supplementary Concept]
- CP 320626 [MeSH Supplementary Concept]
- CPUY013 compound [MeSH Supplementary Concept]
- Caspofungin [MeSH Descriptor]
- Cidofovir [MeSH Descriptor]
- Cl-DACA [MeSH Supplementary Concept]
- DC_MO1 [MeSH Supplementary Concept]
- DFP-10825 [MeSH Supplementary Concept]
- DMP 777 [MeSH Supplementary Concept]
- Decitabine [MeSH Descriptor]
- ERW1041E [MeSH Supplementary Concept]
- FD 501 [MeSH Supplementary Concept]
- FK 409 [MeSH Supplementary Concept]
- FR 74366 [MeSH Supplementary Concept]
- FTI 277 [MeSH Supplementary Concept]
- FYX-051 [MeSH Supplementary Concept]
- Fomepizole [MeSH Descriptor]
- GDC-0084 [MeSH Supplementary Concept]
- GL 331 [MeSH Supplementary Concept]
- GR 122222X [MeSH Supplementary Concept]
- GSK-3326595 [MeSH Supplementary Concept]
- Gatifloxacin [MeSH Descriptor]
- Gemifloxacin [MeSH Descriptor]
- H3B-120 [MeSH Supplementary Concept]
- IPR19 compound [MeSH Supplementary Concept]
- ISIS 5132 [MeSH Supplementary Concept]
- Irinotecan [MeSH Descriptor]
- JNJ-42165279 [MeSH Supplementary Concept]
- JNJ-64619178 [MeSH Supplementary Concept]
- KN 62 [MeSH Supplementary Concept]
- KT 5720 [MeSH Supplementary Concept]
- KT 5926 [MeSH Supplementary Concept]
- KT182 [MeSH Supplementary Concept]
- KT195 [MeSH Supplementary Concept]
- KT203 [MeSH Supplementary Concept]
- KY-226 [MeSH Supplementary Concept]
- LB100 [MeSH Supplementary Concept]
- LDD2269 [MeSH Supplementary Concept]
- LGK974 [MeSH Supplementary Concept]
- LMP517 [MeSH Supplementary Concept]
- LP0040 [MeSH Supplementary Concept]
- LPC-058 [MeSH Supplementary Concept]
- LQFM166 [MeSH Supplementary Concept]
- LY3031207 [MeSH Supplementary Concept]
- Leflunomide [MeSH Descriptor]
- M 79175 [MeSH Supplementary Concept]
- MDL 73811 [MeSH Supplementary Concept]
- ML 7 [MeSH Supplementary Concept]
- ML 9 [MeSH Supplementary Concept]
- Moxifloxacin [MeSH Descriptor]
- N(2)-(4-n-butylphenyl)-2'-deoxyguanosine 5'-triphosphate [MeSH Supplementary Concept]
- N(6)-(1-iminoethyl)lysine [MeSH Supplementary Concept]
- N(G)-iminoethylornithine [MeSH Supplementary Concept]
- N,N-bis(3-(5-bromoacridine-4-carboxamido)propyl)methylamine [MeSH Supplementary Concept]
- N,N-bis(3-(5-methylacridine-4-carboxamido)propyl)methylamine [MeSH Supplementary Concept]
- N,N-dimethylarginine [MeSH Supplementary Concept]
- N,N-dimethylsphingosine [MeSH Supplementary Concept]
- N-((2S,3S)-4,4-difluoro-3-hydroxy-1-(hydroxyamino)-3-methyl-1-oxobutan-2-yl)-4-((4-(morpholinomethyl)phenyl)ethynyl)benzamide [MeSH Supplementary Concept]
- N-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9H-purin-6-amine [MeSH Supplementary Concept]
- N-(2'-(dimethylamino)ethyl)acridine-4-carboxamide [MeSH Supplementary Concept]
- N-(2-(dimethylamino)ethyl)-2-(4-pyridyl)quinoline-8-carboxamide [MeSH Supplementary Concept]
- N-(2-(dimethylamino)ethyl)-5-methyl-4-acridinecarboxamide [MeSH Supplementary Concept]
- N-(3-(aminomethyl)benzyl)acetamidine [MeSH Supplementary Concept]
- N-(3-pyrene)maleimide [MeSH Supplementary Concept]
- N-acetyl-S-farnesylcysteine [MeSH Supplementary Concept]
- N-acetylsphingosine [MeSH Supplementary Concept]
- N-chlorotaurine [MeSH Supplementary Concept]
- N-cyclohexyl-N'-(4-dimethylamino-alpha-naphthyl)carbodiimide [MeSH Supplementary Concept]
- N-hydroxyisoquinolinedione [MeSH Supplementary Concept]
- N-hydroxypyridinedione [MeSH Supplementary Concept]
- N-methyldeoxynojirimycin [MeSH Supplementary Concept]
- N-phenylpyrrolamide [MeSH Supplementary Concept]
- NAAA inhibitor F215 [MeSH Supplementary Concept]
- NB 506 [MeSH Supplementary Concept]
- NG-Nitroarginine methyl ester [MeSH Descriptor]
- NP16 compound [MeSH Supplementary Concept]
- NSC 659687 [MeSH Supplementary Concept]
- NU-ICRF 500 [MeSH Supplementary Concept]
- O(6)-benzylguanine [MeSH Supplementary Concept]
- Orlistat [MeSH Descriptor]
- PC-786 [MeSH Supplementary Concept]
- PCC0208009 [MeSH Supplementary Concept]
- PD 128042 [MeSH Supplementary Concept]
- PD 135042 [MeSH Supplementary Concept]
- PD 138312 [MeSH Supplementary Concept]
- PD 160793 [MeSH Supplementary Concept]
- PD 161148 [MeSH Supplementary Concept]
- PDE7 inhibitor S14 [MeSH Supplementary Concept]
- PF 03376056 [MeSH Supplementary Concept]
- PF-543 [MeSH Supplementary Concept]
- PGIP protein, plant [MeSH Supplementary Concept]
- PL265 [MeSH Supplementary Concept]
- PNU-286607 [MeSH Supplementary Concept]
- PR5-LL-CM01 [MeSH Supplementary Concept]
- QYM201 [MeSH Supplementary Concept]
- R 59022 [MeSH Supplementary Concept]
- RB 101 [MeSH Supplementary Concept]
- RLM001 [MeSH Supplementary Concept]
- RS 5186 [MeSH Supplementary Concept]
- RTKI cpd [MeSH Supplementary Concept]
- RV 538 [MeSH Supplementary Concept]
- Resveratrol [MeSH Descriptor]
- Rum1 protein, S pombe [MeSH Supplementary Concept]
- S 38809 [MeSH Supplementary Concept]
- S-Nitroso-N-Acetylpenicillamine [MeSH Descriptor]
- S-methylisothiopseudouronium [MeSH Supplementary Concept]
- S-methylthiocitrulline [MeSH Supplementary Concept]
- S009-0629 [MeSH Supplementary Concept]
- SAN 58035 [MeSH Supplementary Concept]
- SB 203580 [MeSH Supplementary Concept]
- SQ 28603 [MeSH Supplementary Concept]
- SR 103 [MeSH Supplementary Concept]
- SR 107 [MeSH Supplementary Concept]
- SR 31747 [MeSH Supplementary Concept]
- ST 638 [MeSH Supplementary Concept]
- STNM01 [MeSH Supplementary Concept]
- TAM16 compound [MeSH Supplementary Concept]
- TAN 1496 A [MeSH Supplementary Concept]
- TAN 1496 C [MeSH Supplementary Concept]
- TAN 1496 E [MeSH Supplementary Concept]
- TAN 1518 A [MeSH Supplementary Concept]
- TAN 1518 B [MeSH Supplementary Concept]
- TP0463518 [MeSH Supplementary Concept]
- Terbinafine [MeSH Descriptor]
- U 0126 [MeSH Supplementary Concept]
- UCT 1072M1 [MeSH Supplementary Concept]
- UCT 1072M2 [MeSH Supplementary Concept]
- Umibecestat [MeSH Supplementary Concept]
- VH298 [MeSH Supplementary Concept]
- VRT 125853 [MeSH Supplementary Concept]
- VSW1198 [MeSH Supplementary Concept]
- W 7 [MeSH Supplementary Concept]
- WCK 1734 [MeSH Supplementary Concept]
- WRC 213 [MeSH Supplementary Concept]
- Y 20811 [MeSH Supplementary Concept]
- Y 27632 [MeSH Supplementary Concept]
- YLC2-155 [MeSH Supplementary Concept]
- ZGN-1061 [MeSH Supplementary Concept]
- acetohydroxamic acid [MeSH Supplementary Concept]
- acetovanillone [MeSH Supplementary Concept]
- acetyldigitoxins [MeSH Descriptor]
- acetyldigoxins [MeSH Descriptor]
- acifluorfen [MeSH Supplementary Concept]
- acivicin [MeSH Supplementary Concept]
- aclarubicin [MeSH Descriptor]
- acyclovir triphosphate [MeSH Supplementary Concept]
- adavosertib [MeSH Supplementary Concept]
- ajoene [MeSH Supplementary Concept]
- alatrofloxacin [MeSH Supplementary Concept]
- allopurinol [MeSH Descriptor]
- allosamidin [MeSH Supplementary Concept]
- alpha,beta-methyleneadenosine 5'-diphosphate [MeSH Supplementary Concept]
- alpha-Methyltyrosine [MeSH Descriptor]
- alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide [MeSH Supplementary Concept]
- alpha-fluoromethylhistidine [MeSH Supplementary Concept]
- alpha-lapachone [MeSH Supplementary Concept]
- alrestatin [MeSH Supplementary Concept]
- amifloxacin [MeSH Supplementary Concept]
- aminooxyacetic acid [MeSH Descriptor]
- amitrole [MeSH Descriptor]
- amonafide [MeSH Supplementary Concept]
- androsta-1,4,6-triene-3,17-dione [MeSH Supplementary Concept]
- angiotensin II, Sar(1)-Ile(5)- [MeSH Supplementary Concept]
- annexin A5 [MeSH Descriptor]
- antibiotic 1233A [MeSH Supplementary Concept]
- antofloxacin [MeSH Supplementary Concept]
- aphidicolin [MeSH Descriptor]
- arachidonoylethylene glycol [MeSH Supplementary Concept]
- arachidonyltrifluoromethane [MeSH Supplementary Concept]
- ardisin [MeSH Supplementary Concept]
- asulacrine [MeSH Supplementary Concept]
- atamestane [MeSH Supplementary Concept]
- atovaquone [MeSH Descriptor]
- atractyloside [MeSH Descriptor]
- aureobasidin A [MeSH Supplementary Concept]
- azacitidine [MeSH Descriptor]
- azatoxin [MeSH Supplementary Concept]
- bafilomycin A [MeSH Supplementary Concept]
- bafilomycin A1 [MeSH Supplementary Concept]
- baicalein [MeSH Supplementary Concept]
- baicalin [MeSH Supplementary Concept]
- balofloxacin [MeSH Supplementary Concept]
- baloxavir [MeSH Supplementary Concept]
- bastadin 14 [MeSH Supplementary Concept]
- belotecan [MeSH Supplementary Concept]
- benserazide [MeSH Descriptor]
- benserazide, levodopa drug combination [MeSH Supplementary Concept]
- benzoflavones [MeSH Descriptor]
- besifloxacin [MeSH Supplementary Concept]
- beta-Naphthoflavone [MeSH Descriptor]
- bicozamycin [MeSH Supplementary Concept]
- bis(4-nitrophenyl)phosphate [MeSH Supplementary Concept]
- bis(helenalinyl)glutarate [MeSH Supplementary Concept]
- bis(isoalantodiol-B)glutarate [MeSH Supplementary Concept]
- bis-1,3-((5,6-dihydro-5,11-diketo-11H-indeno(1,2-c)isoquinoline)-6-propylamino)propane [MeSH Supplementary Concept]
- bisindolylmaleimide I [MeSH Supplementary Concept]
- blasticidin S [MeSH Supplementary Concept]
- brequinar [MeSH Supplementary Concept]
- brocresine [MeSH Descriptor]
- bromopyruvate [MeSH Supplementary Concept]
- bufalin [MeSH Supplementary Concept]
- butaselen [MeSH Supplementary Concept]
- buthionine sulfoximine [MeSH Descriptor]
- butyl phosphorotrithioate [MeSH Supplementary Concept]
- callyspongiamide A [MeSH Supplementary Concept]
- callyspongiamide B [MeSH Supplementary Concept]
- calmidazolium [MeSH Supplementary Concept]
- calphostin C [MeSH Supplementary Concept]
- calphostin complex [MeSH Supplementary Concept]
- calyculin A [MeSH Supplementary Concept]
- camptothecin [MeSH Descriptor]
- cantharidin [MeSH Descriptor]
- carbobenzoxycoumarin [MeSH Supplementary Concept]
- cardiac glycosides [MeSH Descriptor]
- carubicin [MeSH Descriptor]
- caspase-activated DNase inhibitor [MeSH Supplementary Concept]
- cauloside A [MeSH Supplementary Concept]
- cetilistat [MeSH Supplementary Concept]
- chlorobiocic acid [MeSH Supplementary Concept]
- chloromercuribenzoates [MeSH Descriptor]
- cinoxacin [MeSH Descriptor]
- cladosporin [MeSH Supplementary Concept]
- clavulanic acids [MeSH Descriptor]
- clinafloxacin [MeSH Supplementary Concept]
- coformycin [MeSH Descriptor]
- concanamycin A [MeSH Supplementary Concept]
- conduritol epoxide [MeSH Supplementary Concept]
- corydaline [MeSH Supplementary Concept]
- costunolide [MeSH Supplementary Concept]
- coumermycin [MeSH Supplementary Concept]
- curcumin [MeSH Descriptor]
- cyanoginosin LR [MeSH Supplementary Concept]
- cyclopentenyl cytosine [MeSH Supplementary Concept]
- cyclopiazonic acid [MeSH Supplementary Concept]
- cyclosporins [MeSH Descriptor]
- cyclothialidine [MeSH Supplementary Concept]
- cystamine [MeSH Descriptor]
- cytidylyl adenosine [MeSH Supplementary Concept]
- daidzin [MeSH Supplementary Concept]
- daunorubicin [MeSH Descriptor]
- dazmegrel [MeSH Supplementary Concept]
- dazoxiben [MeSH Supplementary Concept]
- dehydroaltenusin [MeSH Supplementary Concept]
- demethylzeylasterone [MeSH Supplementary Concept]
- desipramine [MeSH Descriptor]
- deslanoside [MeSH Descriptor]
- deslorelin [MeSH Supplementary Concept]
- dexrazoxane [MeSH Descriptor]
- diacetylmonoxime [MeSH Supplementary Concept]
- dicentrinone [MeSH Supplementary Concept]
- dicyclohexylamine [MeSH Supplementary Concept]
- digitalis glycosides [MeSH Descriptor]
- digitoxin [MeSH Descriptor]
- digoxin [MeSH Descriptor]
- digoxin-like factors [MeSH Supplementary Concept]
- dihydrobenzisoxazole-4-one [MeSH Supplementary Concept]
- diphenyleneiodonium [MeSH Supplementary Concept]
- dipicolinic acid [MeSH Supplementary Concept]
- doxorubicin [MeSH Descriptor]
- doxorubicin-iron complex [MeSH Supplementary Concept]
- elastatinal [MeSH Supplementary Concept]
- eleutherin [MeSH Supplementary Concept]
- eliglustat [MeSH Supplementary Concept]
- emeriamine [MeSH Supplementary Concept]
- eniluracil [MeSH Supplementary Concept]
- epalrestat [MeSH Supplementary Concept]
- epirubicin [MeSH Descriptor]
- erbstatin [MeSH Supplementary Concept]
- eritadenine [MeSH Supplementary Concept]
- estrone-3-O-sulfamate [MeSH Supplementary Concept]
- ethacrynic acid [MeSH Descriptor]
- ethanolamine O-sulfate [MeSH Supplementary Concept]
- ethidium [MeSH Descriptor]
- ethoxidine [MeSH Supplementary Concept]
- ethylmaleimide [MeSH Descriptor]
- etirinotecan pegol [MeSH Supplementary Concept]
- etiron [MeSH Supplementary Concept]
- etomoxir [MeSH Supplementary Concept]
- etoposide [MeSH Descriptor]
- exatecan [MeSH Supplementary Concept]
- fantofarone [MeSH Supplementary Concept]
- farnesylthiosalicylic acid [MeSH Supplementary Concept]
- fenclonine [MeSH Descriptor]
- fenvalerate [MeSH Supplementary Concept]
- finafloxacin [MeSH Supplementary Concept]
- firsocostat [MeSH Supplementary Concept]
- fleroxacin [MeSH Descriptor]
- flumequine [MeSH Supplementary Concept]
- fluoranthene [MeSH Supplementary Concept]
- flurithromycin [MeSH Supplementary Concept]
- fostriecin [MeSH Supplementary Concept]
- fukinolic acid [MeSH Supplementary Concept]
- fulacimstat [MeSH Supplementary Concept]
- fumonisin B1 [MeSH Supplementary Concept]
- furegrelate [MeSH Supplementary Concept]
- gabaculine [MeSH Supplementary Concept]
- garenoxacin [MeSH Supplementary Concept]
- gckr protein, mouse [MeSH Supplementary Concept]
- gladiolin [MeSH Supplementary Concept]
- glucokinase regulatory protein [MeSH Supplementary Concept]
- go 6976 [MeSH Supplementary Concept]
- grepafloxacin [MeSH Supplementary Concept]
- heclin [MeSH Supplementary Concept]
- heliodermin [MeSH Supplementary Concept]
- herbimycin [MeSH Supplementary Concept]
- hexylglutathione [MeSH Supplementary Concept]
- honokiol [MeSH Supplementary Concept]
- huperphlegmine A [MeSH Supplementary Concept]
- huperphlegmine B [MeSH Supplementary Concept]
- hydroxychloroquine [MeSH Descriptor]
- hydroxymercuribenzoates [MeSH Descriptor]
- hypericin [MeSH Supplementary Concept]
- idarubicin [MeSH Descriptor]
- idelalisib [MeSH Supplementary Concept]
- imarikiren hydrochloride [MeSH Supplementary Concept]
- imetelstat [MeSH Supplementary Concept]
- imidazole [MeSH Supplementary Concept]
- indeno(1,2-b)indole-10-one [MeSH Supplementary Concept]
- indolocarbazole derivative R-6 [MeSH Supplementary Concept]
- iodoacetamide [MeSH Descriptor]
- iodoacetates [MeSH Descriptor]
- iodoacetic acid [MeSH Descriptor]
- isbogrel [MeSH Supplementary Concept]
- isoaurostatin [MeSH Supplementary Concept]
- isocamptothecin A [MeSH Supplementary Concept]
- isocamptothecin B [MeSH Supplementary Concept]
- isoliquiritigenin [MeSH Supplementary Concept]
- isovanillin [MeSH Supplementary Concept]
- ivosidenib [MeSH Supplementary Concept]
- juglone [MeSH Supplementary Concept]
- kalihinol F [MeSH Supplementary Concept]
- kibdelomycin A [MeSH Supplementary Concept]
- kifunensine [MeSH Supplementary Concept]
- ku 0063794 [MeSH Supplementary Concept]
- kushenol A [MeSH Supplementary Concept]
- lavendustin A [MeSH Supplementary Concept]
- lawsone [MeSH Supplementary Concept]
- leptosin C [MeSH Supplementary Concept]
- leptosin F [MeSH Supplementary Concept]
- levulinic acid [MeSH Supplementary Concept]
- liarozole [MeSH Supplementary Concept]
- linrodostat [MeSH Supplementary Concept]
- linsidomine [MeSH Supplementary Concept]
- lithium carbonate [MeSH Descriptor]
- lomefloxacin [MeSH Supplementary Concept]
- lonafarnib [MeSH Supplementary Concept]
- lysyl-cysteinyl-cysteinyl-arginyl-cysteinyl-lysine [MeSH Supplementary Concept]
- makaluvamine H [MeSH Supplementary Concept]
- makaluvamine I [MeSH Supplementary Concept]
- makaluvamine N [MeSH Supplementary Concept]
- maleic acid [MeSH Supplementary Concept]
- manumycin [MeSH Supplementary Concept]
- marimastat [MeSH Supplementary Concept]
- marinobufagenin [MeSH Supplementary Concept]
- matadine [MeSH Supplementary Concept]
- meciadanol [MeSH Supplementary Concept]
- medigoxin [MeSH Descriptor]
- merbarone [MeSH Supplementary Concept]
- mercuribenzoates [MeSH Descriptor]
- mersalyl [MeSH Descriptor]
- methyl 2,5-dihydroxycinnamate [MeSH Supplementary Concept]
- methyl 3-(4-(bis(2-chloroethyl)amino)phenyl)-2-(2-(4-((N-isopropyl)amidino)phenyl)furan-5-carboxamido)propanoate [MeSH Supplementary Concept]
- methyl arachidonylfluorophosphonate [MeSH Supplementary Concept]
- methyl diethyldithiocarbamate [MeSH Supplementary Concept]
- methylene blue [MeSH Descriptor]
- metyrapone [MeSH Descriptor]
- microcystin [MeSH Supplementary Concept]
- mitoguazone [MeSH Descriptor]
- mitoxantrone [MeSH Descriptor]
- mizoribine [MeSH Supplementary Concept]
- monastrol [MeSH Supplementary Concept]
- monodansylcadaverine [MeSH Supplementary Concept]
- monorden [MeSH Supplementary Concept]
- mycophenolic acid [MeSH Descriptor]
- myxothiazol [MeSH Supplementary Concept]
- nadifloxacin [MeSH Supplementary Concept]
- nafagrel [MeSH Supplementary Concept]
- nalidixic acid [MeSH Descriptor]
- neocarzinostatin chromophore [MeSH Supplementary Concept]
- neocryptolepine [MeSH Supplementary Concept]
- neplanocin A [MeSH Supplementary Concept]
- nikkomycin [MeSH Supplementary Concept]
- nitisinone [MeSH Supplementary Concept]
- nitroarginine [MeSH Descriptor]
- nojirimycin [MeSH Supplementary Concept]
- norcantharidin [MeSH Supplementary Concept]
- norindenoisoquinoline [MeSH Supplementary Concept]
- novobiocin 401 [MeSH Supplementary Concept]
- o-Phthalaldehyde [MeSH Descriptor]
- obatoclax [MeSH Supplementary Concept]
- okadaic acid [MeSH Descriptor]
- olomoucine [MeSH Supplementary Concept]
- omega-N-Methylarginine [MeSH Descriptor]
- oseltamivir [MeSH Descriptor]
- ouabain [MeSH Descriptor]
- oxolinic acid [MeSH Descriptor]
- oxophenylarsine [MeSH Supplementary Concept]
- oxypurinol [MeSH Descriptor]
- ozagrel [MeSH Supplementary Concept]
- palmitic acid [MeSH Descriptor]
- patuletin [MeSH Supplementary Concept]
- pazufloxacin [MeSH Supplementary Concept]
- peficitinib [MeSH Supplementary Concept]
- peramivir [MeSH Supplementary Concept]
- perillyl alcohol [MeSH Supplementary Concept]
- permethrin [MeSH Descriptor]
- pervanadate [MeSH Supplementary Concept]
- petesicatib [MeSH Supplementary Concept]
- pevonedistat [MeSH Supplementary Concept]
- phencyclidine [MeSH Descriptor]
- phenethyl isothiocyanate [MeSH Supplementary Concept]
- phenylglyoxal [MeSH Descriptor]
- phosphinothricin [MeSH Supplementary Concept]
- phosphoprotein phosphatase inhibitor 1 [MeSH Supplementary Concept]
- phosphoramidic acid [MeSH Supplementary Concept]
- pimagedine [MeSH Supplementary Concept]
- pirmagrel [MeSH Supplementary Concept]
- pixantrone [MeSH Supplementary Concept]
- placental ribonuclease inhibitor [MeSH Supplementary Concept]
- polyoxorim [MeSH Supplementary Concept]
- ponalrestat [MeSH Supplementary Concept]
- potassium cyanide [MeSH Descriptor]
- pqr620 [MeSH Supplementary Concept]
- pritelivir [MeSH Supplementary Concept]
- proadifen [MeSH Descriptor]
- propargylglycine [MeSH Supplementary Concept]
- proscillaridin [MeSH Descriptor]
- protein kinase modulator [MeSH Supplementary Concept]
- protein phosphatase inhibitor-1 [MeSH Supplementary Concept]
- protein phosphatase inhibitor-2 [MeSH Supplementary Concept]
- proteinase inhibitor II protein, plant [MeSH Supplementary Concept]
- prulifloxacin [MeSH Supplementary Concept]
- prunasin [MeSH Supplementary Concept]
- pseudohypericin [MeSH Supplementary Concept]
- pulrodemstat besilate [MeSH Supplementary Concept]
- pyrazofurin [MeSH Supplementary Concept]
- pyrazole [MeSH Supplementary Concept]
- quercetagetin [MeSH Supplementary Concept]
- quinacrine [MeSH Descriptor]
- quinuclidin-3-yl-N-(1-(3-(4-fluorophenyl)phenyl)-1-methyl-ethyl)carbamate [MeSH Supplementary Concept]
- ranirestat [MeSH Supplementary Concept]
- rebamipide [MeSH Supplementary Concept]
- rhein [MeSH Supplementary Concept]
- ribavirin-5'-phosphate [MeSH Supplementary Concept]
- ridogrel [MeSH Supplementary Concept]
- ro 31-7549 [MeSH Supplementary Concept]
- ro 31-8220 [MeSH Supplementary Concept]
- ro 31-8425 [MeSH Supplementary Concept]
- ro 47-3359 [MeSH Supplementary Concept]
- rosettacin [MeSH Supplementary Concept]
- rottlerin [MeSH Supplementary Concept]
- rubitecan [MeSH Supplementary Concept]
- ruboxistaurin [MeSH Supplementary Concept]
- rufloxacin [MeSH Supplementary Concept]
- ruthenium ben [MeSH Supplementary Concept]
- ruthenium sal [MeSH Supplementary Concept]
- safingol [MeSH Supplementary Concept]
- saracatinib [MeSH Supplementary Concept]
- sch 28080 [MeSH Supplementary Concept]
- selitrectinib [MeSH Supplementary Concept]
- serabelisib [MeSH Supplementary Concept]
- simplifungin [MeSH Supplementary Concept]
- sitafloxacin [MeSH Supplementary Concept]
- sobuzoxane [MeSH Supplementary Concept]
- sodium arsenite [MeSH Supplementary Concept]
- sodium azide [MeSH Descriptor]
- sodium cyanide [MeSH Descriptor]
- sodium-potassium ATPase inhibitory factor [MeSH Supplementary Concept]
- sorivudine [MeSH Supplementary Concept]
- sparfloxacin [MeSH Supplementary Concept]
- sparfosic acid [MeSH Supplementary Concept]
- squalestatin 1 [MeSH Supplementary Concept]
- staurosporine [MeSH Descriptor]
- staurosporine aglycone [MeSH Supplementary Concept]
- steroid delta-isomerase [MeSH Supplementary Concept]
- strophanthins [MeSH Descriptor]
- succinylacetone [MeSH Supplementary Concept]
- sulfometuron methyl [MeSH Supplementary Concept]
- surfactin peptide [MeSH Supplementary Concept]
- swainsonine [MeSH Descriptor]
- synaptojanin [MeSH Supplementary Concept]
- tautomycin [MeSH Supplementary Concept]
- tele-methylhistamine [MeSH Supplementary Concept]
- temafloxacin [MeSH Supplementary Concept]
- tendamistate [MeSH Supplementary Concept]
- teniposide [MeSH Descriptor]
- tetra(4-N-methylpyridyl)porphine [MeSH Supplementary Concept]
- tetrathiomolybdate [MeSH Supplementary Concept]
- tezacitabine [MeSH Supplementary Concept]
- thapsigargin [MeSH Descriptor]
- thiamidol [MeSH Supplementary Concept]
- thiazole-4-carboxamide adenine dinucleotide [MeSH Supplementary Concept]
- thiocitrulline [MeSH Supplementary Concept]
- thiosemicarbazide [MeSH Supplementary Concept]
- tin mesoporphyrin [MeSH Supplementary Concept]
- tin protoporphyrin IX [MeSH Supplementary Concept]
- tirbanibulin [MeSH Supplementary Concept]
- tobacco tar [MeSH Supplementary Concept]
- tolrestat [MeSH Supplementary Concept]
- topopyrone A [MeSH Supplementary Concept]
- topopyrone B [MeSH Supplementary Concept]
- topopyrone C [MeSH Supplementary Concept]
- topopyrone D [MeSH Supplementary Concept]
- topostatin [MeSH Supplementary Concept]
- topostin A1 [MeSH Supplementary Concept]
- topostin A2 [MeSH Supplementary Concept]
- topostin B [MeSH Supplementary Concept]
- topotecan [MeSH Descriptor]
- tosedostat [MeSH Supplementary Concept]
- trans-1,4-bis(2-chlorobenzaminomethyl)cyclohexane dihydrochloride [MeSH Descriptor]
- trehalose-6-phosphate [MeSH Supplementary Concept]
- triacsin C [MeSH Supplementary Concept]
- triamcinolone diacetate [MeSH Supplementary Concept]
- trichloroepoxypropane [MeSH Descriptor]
- tridemethyl-N-(4'-nitrobenzoyl)deacetylthiocolchicine [MeSH Supplementary Concept]
- trilostane [MeSH Supplementary Concept]
- trovafloxacin [MeSH Supplementary Concept]
- tryptophyl-tyrosyl-cysteinyl-arginyl-cysteinyl-lysine [MeSH Supplementary Concept]
- tyrphostin 25 [MeSH Supplementary Concept]
- tyrphostin 47 [MeSH Supplementary Concept]
- tyrphostin A23 [MeSH Supplementary Concept]
- tyrphostins [MeSH Descriptor]
- ulifloxacin [MeSH Supplementary Concept]
- uracil-DNA glycosylase inhibitor protein, B. subtilis bacteriophage [MeSH Supplementary Concept]
- valproic acid [MeSH Descriptor]
- valrubicin [MeSH Supplementary Concept]
- valsafungin [MeSH Supplementary Concept]
- vigabatrin [MeSH Descriptor]
- zamicastat [MeSH Supplementary Concept]
- zanamivir [MeSH Descriptor]
- zaragozic acid C [MeSH Supplementary Concept]
- zinc protoporphyrin [MeSH Supplementary Concept]
- zopolrestat [MeSH Supplementary Concept]
UMLS correspondences (same concept)
- Product containing enzyme inhibitor (product) [SNOMED CT concept]
- Substance with enzyme inhibitor mechanism of action (substance) [SNOMED CT concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients